...
首页> 外文期刊>International Seminars in Surgical Oncology >Optimization of FDG-PET/CT imaging protocol for evaluation of patients with primary and metastatic liver disease
【24h】

Optimization of FDG-PET/CT imaging protocol for evaluation of patients with primary and metastatic liver disease

机译:优化FDG-PET / CT成像方案以评估原发性和转移性肝病患者

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Accurate determination of the extrahepatic extent and intrahepatic distribution of disease is very important in patients with primary and metastatic liver disease for deciding whether a patient receives potentially curable surgery or palliative treatment. Our objective was to evaluate the efficacy of delayed phase FDG-PET/CT imaging in lesion detection and to define its clinical impact compared to triple-phase contrast enhanced CT (CECT). Methods 30 patients underwent delayed phase FDG-PET/CT imaging (90 min whole body scan followed by a delayed abdominal scan at 120 min). Maximum standard uptake values (SUVs) and SUV ratios between tumor and normal liver parenchyma (T/N) were evaluated. In addition, comparison was made to CECT obtained within 10 days of the FDG-PET/CT to evaluate for lesion concordance within individual liver segments (Couinaud designation). Results Sites of primary malignancies included: colorectal (19), breast (3), pancreas (2), lung (2), carcinoid (2), cholangiocarcinoma (1), and hepatocellular carcinoma (1). There was a significant increase in SUV value of liver lesions between early and delayed acquisition (P < 0.001). Although there was not a significant reduction in liver background activity between the two studies, there was a strong increase in T/N ratio (P < 0.001) allowing better lesion detection by visual inspection. New lesions were identified in 5 of the 30 patients, which were not appreciated on the early scan. Delayed phase FDG-PET/CT identified one lesion which was not present on the corresponding CECT. Delayed phase FDG-PET/CT revealed extrahepatic sites of metastases not appreciated on CECT in 6 patients. Conclusion Delayed phase FDG-PET/CT protocol improved lesion detectability in primary and metastatic liver disease, revealing new lesions in 17% of the patients. Moreover, FDG-PET/CT identified extrahepatic disease not seen on CECT in 20% of the patients.
机译:背景技术对于患有原发性和转移性肝病的患者,准确确定疾病的肝外范围和肝内分布对于确定患者是否接受可能的手术或姑息治疗非常重要。我们的目的是评估延迟相FDG-PET / CT成像在病变检测中的功效,并确定其与三相对比增强CT(CECT)相比的临床影响。方法30例患者接受了延迟期FDG-PET / CT成像(90分钟的全身扫描,然后在120分钟的延迟腹部扫描)。评估了肿瘤与正常肝实质之间的最大标准摄取值(SUV)和SUV比(T / N)。此外,与在FDG-PET / CT的10天内获得的CECT进行了比较,以评估单个肝节段内的病变一致性(Couinaud名称)。结果原发性恶性肿瘤的部位包括:结肠直肠癌(19),乳腺癌(3),胰腺(2),肺(2),类癌(2),胆管癌(1)和肝细胞癌(1)。在早期和延迟采集之间,肝脏病变的SUV值显着增加(P <0.001)。尽管在两项研究之间肝本底活性没有显着降低,但T / N比却大大增加(P <0.001),从而可以通过肉眼检查更好地检测病变。在30例患者中有5例发现了新病灶,早期扫描未发现新病灶。延迟相FDG-PET / CT鉴别出相应CECT上不存在的一个病变。延迟期FDG-PET / CT显示6例患者的肝外转移灶未在CECT上发现。结论延迟期FDG-PET / CT方案可改善原发性和转移性肝病的病灶检测能力,在17%的患者中发现新病灶。此外,FDG-PET / CT确定了20%的患者在CECT上未见肝外疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号